Premium
Treatment of IgA nephropathy in children
Author(s) -
YOSHIKAWA Norishige
Publication year - 2002
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.2002.tb00528.x
Subject(s) - medicine , nephropathy , glomerulonephritis , pathogenesis , disease , immunology , kidney , endocrinology , diabetes mellitus
SUMMARY: IgA nephropathy is the most common primary glomerulonephritis in the world, and about 20–50% of patients develop progressive renal failure. the pathogenesis is still unknown and treatment has not yet been established. Knowledge concerning childhood IgA nephropathy has expanded greatly in the last 10 years, and its importance as the major form of glomerulonephritis and major contributor to end‐stage renal disease is also becoming apparent in children. This communication focuses on the treatment of IgA nephropathy in children.